Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network.
Daniela SegalaMarco BarbieriMariachiara Di NuzzoMelissa BenazziAurora BonazzaLetizia RomaniniBrunella QuartaKristian ScolzAnna MarraDiana CampioniRosario CultreraPublished in: Global & regional health technology assessment (2024)
Dalbavancin has proven to be a valid therapeutic aid in the organization of a territorial infectious disease network given its prolonged action, which allows the dehospitalization with management of even patients with complex infections in outpatient parenteral antimicrobial therapy.